Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
GHK-Cu 50 mg Peptide (Research Grade) $129.00 Out of stock Guarantee safe & secure checkout Description Key features: Naturally occurring copper peptide complex found in human plasma, saliva, and urin Lyophilised for stability, easy reconstitution Suitable for subcutaneous administration in approved research protocols Stored refrigerated at 28C after delivery Suggested reconstitution (research use only) Reconstitute 50 mg with 5 mL bacteriostatic water to yield 10,000 mcg/mL
How does glutathione support health
This product is designed to provide users with a lot of benefits while they are working on improving their skin
NAMPT modulators As described above, NAMPT is a key enzyme in the NAD + biosynthesis pathway via salvage, converting NAM into NMN 209
Investigating BPC-157's Potential: From Pre-clinical Foundations to 2026 Clinical Insights Research into BPC-157 (Body Protection Compound-157) has evolved from specialized laboratory observations into a cornerstone of regenerative medicine
